AI assistant
Sending…
METLIFE INC — Director's Dealing 2022
Feb 25, 2022
29995_dirs_2022-02-24_8ba44433-58a3-43ef-9ded-bb89f35090bf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: METLIFE INC (MET)
CIK: 0001099219
Period of Report: 2022-02-22
Reporting Person: GAUSTER STEPHEN W (EVP & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-22 | Common Stock | A | 3622 | — | Acquired | 25342 | Direct |
| 2022-02-22 | Common Stock | A | 26582 | — | Acquired | 51924 | Direct |
| 2022-02-22 | Common Stock | F | 12549 | $68.96 | Disposed | 39375 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-02-22 | Employee Stock Options (right to buy) | $68.96 | A | 10864 | Acquired | 2032-02-21 | Common Stock (10864.0) | Direct |
Footnotes
F1: Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F2: Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F3: Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.
F4: The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.
More from METLIFE INC
Notice of Dividend Amount
2026
May 15
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 29
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Director's Dealing
2026
Mar 19